Back to search

Article

The CD28-transmembrane domain mediates chimeric antigen receptor heterodimerization with CD28

2020-09-19

Abstract excerpt

Anti-CD19 chimeric antigen receptor (CD19-CAR)-engineered T cells are approved therapeutics for malignancies. The impact of the hinge (HD) and transmembrane (TMD) domains between the extracellular antigen-targeting and the intracellular signaling modalities of CARs has not been systemically studied. Here, a series of CD19-CARs differing only by their HD (CD8/CD28/IgG 4 ) and TMD (CD8/CD28) was generated. CARs con...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6742bdd7-bee2-546e-8fc0-9d07a6401d7c
DOI
10.1101/2020.09.18.296913
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The CD28-transmembrane domain mediates chimeric antigen receptor heterodimerization with CD28DOI 10.1101/2020.09.18.296913
Select a neighboring publication to make it the new centre.